Trial Profile
F9 Genotype and pharmacokinetics (PK) Hemophilia B International Study
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 10 Mar 2022
Price :
$35
*
At a glance
- Drugs Nonacog alfa (Primary)
- Indications Haemophilia B
- Focus Pharmacodynamics; Pharmacokinetics
- Acronyms GePKHIS
- 10 Mar 2022 Status changed from recruiting to discontinued.
- 08 Oct 2021 Results (n=30) of a PK analysis assessing HB mutational patterns and phenotypes associated to recurrent substitutions at FIX activation sites; using plasma samples enrolled in this trial published in the Journal of Thrombosis and Haemostasis
- 26 Mar 2018 New trial record